Oldvatr
Expert
This is interesting. It is a report from a hospital regarding CVE admissions.
www.cureus.com
In th Outcomes section, they report that some patients suffered further MI events, and this is their analysis
"The rate of reinfarction was significantly higher among patients on lipid-lowering medications before their first hospital admission than among those who were not on medication (22.97% and 10.61%, respectively, P = 0.012)."
And also
"The readmission percentage was higher among females than among males (19.35% and 15.47%, respectively). Patients on lipid-lowering medications before hospital admission had a higher percentage of readmission than medically free patients (20.27% and 9.49%, respectively, P = 0.014). NSTEMI was the most common presentation among all readmissions."
These are actual admissions to coronary care, so not a fabricated drug study.
But here is a connundrum in the report. The conclusion section reads completely differently, and appears to be written by another author. The conclusion section extols the virtues of using statins and that people need to get their LDL <1.8 mmol/l. There is no reference to the quotes I noted above, and indeed there is another para where it was stated that the readmission group had considerably reduced their LDL-c levels since discharge from the first admission, but still had a readmission for MI. There was no reference to this at all in the conclusion. I wonder who paid the piper?

Demographics and Characteristics of Patients Admitted With Acute Coronary Syndrome to the Coronary Care Unit at King Abdulaziz University
Background Over the previous decade, the incidence of cardiovascular diseases (CVDs) has risen in the Middle East and will increase mortality to 23 million individuals in Saudi Arabia by 2030, according to the Saudi Ministry of Health. CVDs, including acute coronary syndrome (ACS), are the most...

"The rate of reinfarction was significantly higher among patients on lipid-lowering medications before their first hospital admission than among those who were not on medication (22.97% and 10.61%, respectively, P = 0.012)."
And also
"The readmission percentage was higher among females than among males (19.35% and 15.47%, respectively). Patients on lipid-lowering medications before hospital admission had a higher percentage of readmission than medically free patients (20.27% and 9.49%, respectively, P = 0.014). NSTEMI was the most common presentation among all readmissions."
These are actual admissions to coronary care, so not a fabricated drug study.
But here is a connundrum in the report. The conclusion section reads completely differently, and appears to be written by another author. The conclusion section extols the virtues of using statins and that people need to get their LDL <1.8 mmol/l. There is no reference to the quotes I noted above, and indeed there is another para where it was stated that the readmission group had considerably reduced their LDL-c levels since discharge from the first admission, but still had a readmission for MI. There was no reference to this at all in the conclusion. I wonder who paid the piper?
Last edited: